7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Adagene Inc
(NASDAQ:ADAG) 

ADAG stock logo

Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its products include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the ...

Founded: 2011
CEO: Peter Luo  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Adagene Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 020.6741.3562.0282.7103.37124.05144.72
Adagene Days Receivable Outstanding ttm (DSO)
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 0449.18898.361,347.531,796.712,245.892,695.073,144.24
Adagene Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -1.08-0.86-0.64-0.41-0.190.040.260.49
Adagene Free Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -1.15-0.91-0.67-0.44-0.20.030.270.51
Adagene Cash Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 00.621.241.872.493.113.734.36
Adagene P/S ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 013.4326.8640.2953.7267.1580.5894.01
Adagene (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -2.84-2.44-2.03-1.62-1.22-0.81-0.410
Adagene P/B ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 00.320.650.971.31.621.942.27
No extra charts and metrics for this ticker.